Epoprostenol Sodium
Spécifications
61849-14-7Numéro CAS
263-273-7Numéro CE
sodium (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoateNom IUPAC
C20H31NaO5Formule chimique
374.4 g/molMasse molaire
Epoprostenol sodium; 61849-14-7; Prostacyclin sodium salt; Cyclo-Prostin; Sodium prostacyclin; DTXSID3046617; 4K04IQ1OF4; U-53217A; U-53,217A; DTXCID1026617; Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, sodium salt, (5Z,9alpha,11alpha,13E,15S)-; RefChem:57240; 263-273-7; Sodium(Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate; Flolan; Prostacyclin sodium; Sodium (Z)-5-((3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxyoct-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-ylidene)pentanoate; C20H31NaO5; sodium;(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate; Epoprostenol sodium [USAN:BAN]; NCGC00167427-01; EINECS 263-273-7; UNII-4K04IQ1OF4; U 53,217A; Epoprostenolsodium; (5Z,9?,11?,13E,15S)-6,9-epoxy-11,15-Dihydroxy-prosta-5,13-dien-1-oic Acid Sodium Salt; Epoprostenol Sodium; Flolan;; Prostaglandin X sodium; Prostaglandin I2 sodium; PROSTAGLANDIN I2 Na; CHEMBL962; Sodium (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dien-1-oate; SCHEMBL41344; Sodium (Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate; BML1-F10; orb1707331; Prostaglandin I2 (sodium salt); EX-A7849M; EPOPROSTENOL SODIUM [JAN]; 4UA76; EPOPROSTENOL SODIUM [USAN]; HMS1361K18; HMS3648L14; EPOPROSTENOL SODIUM [VANDF]; EPOPROSTENOL SODIUM [MART.]; Tox21_112431; EPOPROSTENOL SODIUM [USP-RS]; EPOPROSTENOL SODIUM [WHO-DD]; PROSTACYCLIN SODIUM SALT [MI]; AKOS024457370; EBC-127030; FP27241; EPOPROSTENOL SODIUM [ORANGE BOOK]; AC-38149; CAS-61849-14-7; NS00074283; T15238; Q27259818; (5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxy-prosta-5,13-dien-1-oic acid sodium; Sodium (5Z,13E,15S)-11beta,15-dihydroxy-9beta,12alpha-6,9-epoxyprosta-5,13-dien-1-oate; PROSTA-5,13-DIEN-1-OIC ACID, 6,9-EPOXY-11,15-DIHYDROXY-, SODIUM SALT, (5Z,9.ALPHA.,11.ALPHA.,13E,15S)-; SODIUM (Z)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-((E)-(3S)-3-HYDROXY-1-OCTENYL)-2H-CYCLOPENTA(B)FURAN-.DELTA.(SUP 2,.DELTA.)-VALERATESynonymes
Produits contenant Epoprostenol Sodium
VELETRI 1,5 MG POLVO PARA SOLUCION PARA PERFUSIONVELETRI 0,5 MG POLVO PARA SOLUCION PARA PERFUSIONEPOPROSTENOL SUN 1,5 MG POLVO PARA SOLUCION PARA PERFUSIONVELETRI 1,5 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONVELETRI 0,5 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONFLOLAN 0,5 mg POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONVELETRI 1,5 mg, poudre et solvant pour solution pour perfusionVELETRI 0,5 mg, poudre et solvant pour solution pour perfusionEpoprostenol Sodium - Zhejiang Ausun PharmaceuticalEpoprostenol Sodium - Cayman Pharma s.r.oEpoprostenol Sodium - Pfizer CentreOneEpoprostenol Sodium - MSN Laboratories
Page 1 sur 2
Entreprises vendant Epoprostenol Sodium
ML
MSN LaboratoriesIndiaZA
Zhejiang Ausun PharmaceuticalChinaSP
Sun Pharmaceutical Industries (Europe) B.V.NetherlandsJI
Janssen-Cilag International N.VSpainJC
JANSSEN CILAG INTERNATIONAL NVFrancePC
Pfizer CentreOneUnited StatesPage 1 sur 2